« Return to News | Clinical Intelligence

Quest, Genomic collaborate

Friday, July 15, 2011 10:25 AM

Quest Diagnostics and Genomic Vision announced a multi-year exclusive collaboration involving Genomic Vision's proprietary molecular combing genomic-analysis technology.

Quest Diagnostics has exclusive rights to develop and offer clinical- and research-use laboratory testing services based on Genomic Vision's molecular combing (also known as DNA combing) technique in the U.S., India and Mexico. Genomic Vision will retain rights to market new testing services that emerge from the collaboration's research and development in Europe (with the exception of the United Kingdom), the Middle East and Africa. Quest Diagnostics has also made an equity investment for an undisclosed sum in Genomic Vision.

DNA combing is an analytical technique that involves stretching coils of DNA into straight chains to facilitate direct high-resolution analysis of targeted areas of the human genome. The technique detects genetic mutations, most notably large scale gene rearrangements, which current DNA analytical technologies cannot detect.

Quest Diagnostics expects to validate and release the first laboratory developed test based on molecular combing, for aiding the detection of individuals affected with facioscapulohumeral muscular dystrophy, in 2012.

The companies will also focus on developing tests for cancer and neurological disorders, with testing services to be offered to clients of Quest Diagnostics.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.